Nairobi, October 9, 2024 – Dr. F.M. Siyoi, the CEO of the Pharmacy and Poisons Board (PPB), chaired the inaugural Partners Forum aimed at enhancing collaboration among partners and stakeholders. During the forum, Dr. Siyoi emphasized the importance of promoting a unified strategic and coordinated approach to regulatory systems to improve access to safe Health Products and Technologies (HPTs). He expressed gratitude to the partners, including the World Health Organization (WHO), the Medicines, Technologies, and Pharmaceutical Services (MTaPS), USAID, the Bill & Melinda Gates Foundation, Strathmore University and the United States Pharmacopeia (USP), among others, for their continued support of PPB programs in promoting the quality and safety of medicines. Dr. Siyoi highlighted that the forum, which will meet quarterly, is designed to support PPB strategies to enhance medicine safety and advance Kenya’s goal of achieving WHO Maturity Level 3 by the end of 2025.